
OS Therapies to Present at The Jones Healthcare and Technology Innovation Conference: A Professionally-Focused Overview
OS Therapies to Present at The Jones Healthcare and Technology Innovation Conference OS Therapies, a pioneering clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company, has announced that its CEO, Paul Romness, and CBO, Gerald Commissiong, will be participating in meetings with registered investors at The Jones Healthcare and Technology Innovation Conference. This event is…